Found: 5
Select item for more details and to access through your institution.
Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 1, p. 131, doi. 10.3390/pharmaceutics15010131
- By:
- Publication type:
- Article
In Vitro–In Vivo Relationship in Mini-Scale—Enabling Formulations of Corallopyronin A.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 8, p. 1657, doi. 10.3390/pharmaceutics14081657
- By:
- Publication type:
- Article
Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 11, p. 1105, doi. 10.3390/pharmaceutics12111105
- By:
- Publication type:
- Article
Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections.
- Published in:
- PLoS Neglected Tropical Diseases, 2020, v. 14, n. 12, p. 1, doi. 10.1371/journal.pntd.0008930
- By:
- Publication type:
- Article
The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in Staphylococcus aureus.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 7, p. 920, doi. 10.3390/antibiotics11070920
- By:
- Publication type:
- Article